 Frans Van de Werf MD, PhD and fellow of the European Society of Cardiology (FESC), the American College of Cardiology (ACC) and the American Heart Association (FAHA) is a Belgian cardiologist at the University Hospital Leuven and a professor of medicine at the Katholieke Universiteit Leuven. He is chair of the university hospital's cardiovascular medicine department. His research is focused on acute coronary syndromes, thrombolysis and antithrombotic treatment. His doctoral thesis was an early treatise on the mechanism underlying the gallop rhythm in heart failure. Later, he collaborated in Leuven with Désiré Collen to discover the clinical application of tissue plasminogen activator (tPA). Professor Van de Werf is Editor-in-Chief of the European Heart Journal and is a member of the editorial boards of Circulation, International Journal of Cardiology, Coronary artery disease, Journal of Thrombosis and Thrombolysis. He was awarded the 2005 Joseph Maisin prize for €100000. 
